TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8695136

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 0.75 mg/kg/min for induction and variable-rate propofol infusion up to 0.15 mg/kg/min for maintenance
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiopental bolus 2 to 4 mg/kg for induction and isoflurane 0.5% to 1.5% for maintenance
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both anesthetic groups
Number of subjects: 60
Study: 1628772

Group type: EXPERIMENTAL
Intervention: Glibenclamide treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (normal, nondiabetic subjects)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Baseline study in NIDDM patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Placebo in NIDDM patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glibenclamide in NIDDM patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glibenclamide plus placebo FFAs in NIDDM patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FFAs exogenously increased
Number of subjects: 10
Study: 6360752

Group type: EXPERIMENTAL
Intervention: Pivampicillin (Pondocillin) 500 mg twice daily
Number of subjects: 463

Group type: COMPARATOR
Intervention: Amoxycillin (Amoxil) 250 mg three times daily
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Pivampicillin (Pondocillin)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Amoxycillin (Amoxil)
Number of subjects: 463
Study: 29393671

Group type: EXPERIMENTAL
Intervention: Maternal dietary proteins in human milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continued breastfeeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exclusion diets
Number of subjects: 0
Study: 28222465

Group type: EXPERIMENTAL
Intervention: Autologous Conditioned Plasma (ACP) injection therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl) injection therapy
Number of subjects: 50
Study: 26121200

Group type: EXPERIMENTAL
Intervention: PCV13 + DTaP
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTaP
Number of subjects: 0
Study: 23566212

Group type: EXPERIMENTAL
Intervention: HPβCD diclofenac, administered as a small-volume bolus injection every 6 hours for ≥2 days
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: HPβCD diclofenac
Number of subjects: 971
Study: 21752004

Group type: EXPERIMENTAL
Intervention: Completing a kindness questionnaire
Number of subjects: 0

Group type: COMPARATOR
Intervention: Completing an opinions questionnaire (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Writing an essay about a cherished value
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Writing an essay about kindness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Completing a questionnaire about kindness
Number of subjects: 0
Study: 19803575

Group type: EXPERIMENTAL
Intervention: Attention Modification Program (AMP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Attention Control Condition (ACC)
Number of subjects: 44
Study: 16616662

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 17030753

Group type: EXPERIMENTAL
Intervention: Cognitive complaints
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Aging‐associated cognitive decline (AACD)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mild functional impairment
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Amnestic MCI
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Age group 40 to 54 years
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Age group 55 to 69 years
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Age group 70 to 85 years
Number of subjects: 494
Study: 10527954

Group type: EXPERIMENTAL
Intervention: Urodilatin (0, 10, 30, or 60 ng/kg/min) combined with inhaled albuterol (200 microg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Urodilatin (0, 10, 30, or 60 ng/kg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (200 microg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of urodilatin and albuterol
Number of subjects: 12
Study: 8892515

Group type: EXPERIMENTAL
Intervention: High alcohol beer (4.9% alcohol v/v)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low alcohol beer (0.9% alcohol v/v)
Number of subjects: 27
Study: 1803766

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6619565

Group type: EXPERIMENTAL
Intervention: Coal tar exposure with UVA irradiation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Methods of tar removal (more than water alone)
Number of subjects: 32
Study: 31888565

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Running therapy (3 times/week for 16 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: No treatment (healthy controls)
Number of subjects: 160
Study: 30042064

Group type: EXPERIMENTAL
Intervention: Vaccine (three doses, intramuscular at 0, 1, and 2 months)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (three doses, intramuscular at 0, 1, and 2 months)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 63
Study: 27681760

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation therapy (PMRT)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Negative ALND results with ≥3 positive SLNs
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Negative ALND results
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Pathologic stage III
Number of subjects: 345
Study: 25343398

Group type: EXPERIMENTAL
Intervention: Two-implant mandibular overdenture (IOD)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Standard mandibular complete denture (CD)
Number of subjects: 255
Study: 22716205

Group type: EXPERIMENTAL
Intervention: Oral health literacy intervention consisting of five culturally sensitive workshops over 12 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving the intervention 12 months after enrollment.
Number of subjects: 0
Study: 20002654

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both IPL and PDL
Number of subjects: 20
Study: 18410206

Group type: EXPERIMENTAL
Intervention: Psychoeducational program for parents (4 sessions)
Number of subjects: 90
Study: 15838784

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Combination therapy (Azithromycin + Chloroquine)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 12032876

Group type: EXPERIMENTAL
Intervention: AZT + 3TC + NVP
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: d4T + 3TC + NVP
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: d4T + ddI + NVP
Number of subjects: 70
Study: 10089860

Group type: EXPERIMENTAL
Intervention: Permanent pacing for hypertrophic obstructive cardiomyopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing for dilated cardiomyopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing for prevention of atrial fibrillation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing for neurocardiogenic syncope
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing for long QT syndrome
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing after cardiac transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permanent pacing for hemodynamic improvement in first-degree atrioventricular block
Number of subjects: 0
Study: 8942493

Group type: EXPERIMENTAL
Intervention: GYNE-T 380
Number of subjects: 592

Group type: COMPARATOR
Intervention: GYNE-T 380 Postpartum
Number of subjects: 592
Study: 1749710

Group type: EXPERIMENTAL
Intervention: Hospital-prepared product containing 0.5% dithranol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Commercial product containing 0.5% dithranol
Number of subjects: 35
Study: 28853328

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 31
Study: 30900083

Group type: EXPERIMENTAL
Intervention: Restorative Practices Intervention
Number of subjects: 2771

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 2771
Study: 28849269

Group type: EXPERIMENTAL
Intervention: Remote magnetic navigation (RMN)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Manual approach
Number of subjects: 218
Study: 25736101

Group type: EXPERIMENTAL
Intervention: Propofol with remifentanil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Desflurane with remifentanil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study: 23869940

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Vitamin D sterols and phosphate binders alone)
Number of subjects: 0
Study: 22321497

Group type: EXPERIMENTAL
Intervention: Low-energy selective laser trabeculoplasty (SLT) using half of conventional laser energy and 100 spots over 360° of the trabecular meshwork.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional laser energy (control group).
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low-energy selective laser trabeculoplasty (SLT) in POAG.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional laser energy (control group) in POAG.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Complications from low-energy SLT.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Complications from conventional laser energy.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Transient IOP spike (≥ 3 mm Hg) in control group.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Partial peripheral anterior synechiae in control group.
Number of subjects: 74
Study: 19671259

Group type: EXPERIMENTAL
Intervention: Postirradiated NPC patients with CNS infection
Number of subjects: 18

Group type: COMPARATOR
Intervention: NPC patients without CNS infection (control group)
Number of subjects: 18
Study: 17557984

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg + LCD (one meal-replacement shake; two low-calorie meals; total kcal/d approximately 1200-1500)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg + LCD
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo + three low-calorie meals (total kcal/d approximately 1200-1500)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo + three low-calorie meals
Number of subjects: 148
Study: 15572994

Group type: EXPERIMENTAL
Intervention: Tai Chi exercises for 1 hour twice weekly for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Physiotherapy exercises focused on improvement of balance for 1 hour twice weekly for 12 weeks
Number of subjects: 18
Study: 11507354

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily plus cisapride 20 mg twice daily
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 350
Study: 9631925

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CsA) administered twice daily
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CsA) with concomitant diltiazem administration
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Predictive performance assessment in a reserved subset of 33 patients
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Population modeling using NONMEM
Number of subjects: 69
Study: 7517238

Group type: EXPERIMENTAL
Intervention: H1/H2 receptor blockers (1 mg/kg ranitidine and 0.1 mg/kg dimetinden) administered 15 min before protamine administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: No medication (Control group)
Number of subjects: 20
Study: 2525044

Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mivacurium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mivacurium and Suxamethonium
Number of subjects: 0
Study: 4914614

Group type: EXPERIMENTAL
Intervention: Methyprylon (300 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glutethimide (500 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chloral hydrate (1000 mg)
Number of subjects: 50
Study: 31287963

Group type: EXPERIMENTAL
Intervention: High-intensity exercise intervention with daily HRV monitoring
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Moderation of exercise volume in response to HRV shifts
Number of subjects: 55
Study: 30520964

Group type: EXPERIMENTAL
Intervention: Conservative surgery (laparoscopic salpingotomy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy (Methotrexate)
Number of subjects: 0
Study: 28167180

Group type: EXPERIMENTAL
Intervention: Pilates group (PG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 26517847

Group type: EXPERIMENTAL
Intervention: Immediate screening
Number of subjects: 851535

Group type: EXPERIMENTAL
Intervention: Postponed screening
Number of subjects: 851535

Group type: COMPARATOR
Intervention: Never invited
Number of subjects: 851535
Study: 23291565

Group type: EXPERIMENTAL
Intervention: High impact unilateral exercise intervention (50 multidirectional hops, 7 days a week on one leg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control leg (no exercise)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High impact unilateral exercise intervention
Number of subjects: 50
Study: 20974593

Group type: EXPERIMENTAL
Intervention: Prostaglandin D₂ (PGD₂) infusion at 384 ng/kg/min over 25 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Prostaglandin D₂ (PGD₂) infusion
Number of subjects: 12
Study: 18647212

Group type: EXPERIMENTAL
Intervention: Behavioural change techniques
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care treatment (dietitians with no formal training in behavioural change techniques)
Number of subjects: 17
Study: 16234224

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg (4 capsules taken one hour before sexual activity for 2 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (4 identical capsules for 2 weeks)
Number of subjects: 10
Study: 15127994

Group type: EXPERIMENTAL
Intervention: Combination of bovine hydroxyapatite (Bio‐Oss) and autogenous bone chips stabilized with Tisseel
Number of subjects: 30
Study: 10736385

Group type: EXPERIMENTAL
Intervention: Monosodium L-glutamate (MSG) 1.5 g/person
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Monosodium L-glutamate (MSG) 3.0 g/person
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8615394

Group type: EXPERIMENTAL
Intervention: DHEA 50 mg orally thrice daily for 12 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1394753

Group type: EXPERIMENTAL
Intervention: Caudal injection of 1.0 ml.kg-1 bupivacaine 0.125% with epinephrine 1:400,000 and fentanyl 1.0 microgram.kg-1 in 1.0 ml of normal saline
Number of subjects: 34

Group type: COMPARATOR
Intervention: Caudal injection of 1.0 ml.kg-1 bupivacaine 0.125% with epinephrine 1:400,000 and normal saline
Number of subjects: 34
Study: 4059300

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.03 mg/kg)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Thiopentone (5 mg/kg) plus gallamine (0.3 mg/kg)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Thiopentone (5 mg/kg)
Number of subjects: 93
Study: 31174579

Group type: EXPERIMENTAL
Intervention: Home-based virtual reality training (VRT) for standing balance, stepping, reaching, strengthening, and gentle aerobic fitness, performed for 30 minutes, 5 days a week for 6 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: iPad with apps selected to rehabilitate cognition, hand fine motor skills, and visual tracking/scanning, performed for 30 minutes, 5 days a week for 6 weeks.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (VRT and control) will be assessed for standing balance, gait, and community integration.
Number of subjects: 40
Study: 29034524

Group type: EXPERIMENTAL
Intervention: Intravenous dopamine infusion (3 μg kg-1 min-1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 9
Study: 26777066

Group type: EXPERIMENTAL
Intervention: INTERACT quality improvement program
Number of subjects: 64
Study: 24835247

Group type: EXPERIMENTAL
Intervention: Measles vaccine (MV)
Number of subjects: 0
Study: 23224924

Group type: EXPERIMENTAL
Intervention: Oral L-citrulline supplementation (3 g/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (without supplementation)
Number of subjects: 35
Study: 20927359

Group type: EXPERIMENTAL
Intervention: IET + AC (intervention group, n=246)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Nasal suction (NS, control group, n=250)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: IET + AC (intervention group)
Number of subjects: 496
Study: 17986309

Group type: EXPERIMENTAL
Intervention: Topical fulvestrant 70 mg mL(‐1) solution
Number of subjects: 172

Group type: COMPARATOR
Intervention: Minoxidil 2% solution
Number of subjects: 172

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 172
Study: 15824848

Group type: EXPERIMENTAL
Intervention: Intravenous neridronate (2 mg/kg infused IV in 30 minutes every 3 months)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (no treatment for the first year)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intravenous neridronate
Number of subjects: 64
Study: 11809521

Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9708651

Group type: EXPERIMENTAL
Intervention: Early primary ventricular fibrillation (VF)
Number of subjects: 9720

Group type: EXPERIMENTAL
Intervention: Late primary ventricular fibrillation (VF)
Number of subjects: 9720

Group type: COMPARATOR
Intervention: Matched controls (no primary VF)
Number of subjects: 9720
Study: 7636529

Group type: EXPERIMENTAL
Intervention: Schedule 1: Etoposide 130 mg/m2/d IV for 3 days and cisplatin 25 mg/m2/d IV for 3 days every 21 days for eight courses.
Number of subjects: 306

Group type: COMPARATOR
Intervention: Schedule 2: Etoposide 50 mg/m2/d orally for 21 days and cisplatin 33 mg/m2/d IV for 3 days every 28 days for six courses.
Number of subjects: 306
Study: 1964470

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody BW 494
Number of subjects: 150
Study: 638442

Group type: EXPERIMENTAL
Intervention: isotonic sodium chloride
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 per cent glucose in water
Number of subjects: 12
Study: 30958962

Group type: EXPERIMENTAL
Intervention: Peer-led dental education (PLDE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dental instruction (CDI)
Number of subjects: 0
Study: 29438120

Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CLs)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Distance single-vision (SV) spectacles
Number of subjects: 74
Study: 26869609

Group type: EXPERIMENTAL
Intervention: 1200 kcal/d
Number of subjects: 36

Group type: COMPARATOR
Intervention: 500 kcal/d
Number of subjects: 36
Study: 24884684

Group type: EXPERIMENTAL
Intervention: Sealant application (experimental group - n=17)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Restoration with composite resin (control group - n=19)
Number of subjects: 36
Study: 22896584

Group type: EXPERIMENTAL
Intervention: CRT-ICD
Number of subjects: 229
Study: 19839966

Group type: EXPERIMENTAL
Intervention: sustained-release dexamphetamine (up to 110 mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study: 17653683

Group type: EXPERIMENTAL
Intervention: Style 410 implants (MG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vertex implants (ES)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both implants (MG and ES)
Number of subjects: 80
Study: 16287669

Group type: EXPERIMENTAL
Intervention: Ice plus pulsed electromagnetic field (group A)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Ice plus sham pulsed electromagnetic field (group B)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Pulsed electromagnetic field alone (group C)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham pulsed electromagnetic field treatment (group D)
Number of subjects: 83
Study: 12039025

Group type: EXPERIMENTAL
Intervention: CT fluoroscopy
Number of subjects: 20
Study: 10546860

Group type: EXPERIMENTAL
Intervention: Combination regimens of two nucleoside analogues
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Zidovudine combined with either didanosine or zalcitabine
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Triple regimen including a protease inhibitor
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Zidovudine monotherapy
Number of subjects: 10000
Study: 7721576

Group type: EXPERIMENTAL
Intervention: Nitroglycerin applied to the frontotemporal region (5 mg in 2% ointment for 2 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nitroglycerin applied to the neck, arm, and forearm regions (5 mg in 2% ointment for 2 hours)
Number of subjects: 100
Study: 2044338

Group type: EXPERIMENTAL
Intervention: Initial family interview (I)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Non-interviewed (NI)
Number of subjects: 177
Study: 7304900

Group type: EXPERIMENTAL
Intervention: Extradural analgesia (modified technique with reduced bupivacaine concentration)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Extradural analgesia
Number of subjects: 611

Group type: COMPARATOR
Intervention: No extradural analgesia
Number of subjects: 611
Study: 31416453

Group type: EXPERIMENTAL
Intervention: Computerised guideline support tool
Number of subjects: 168

Group type: COMPARATOR
Intervention: Paper-based guideline (control)
Number of subjects: 168
Study: 26406600

Group type: EXPERIMENTAL
Intervention: Bendex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovis
Number of subjects: 0